Trades on 1 secondary market

Pheon Therapeutics

Pheon Therapeutics is a preclinical-stage oncology biotechnology company developing next-generation antibody-drug conjugates (ADCs) for a wide range of hard-to-treat solid tumors. Leveraging two decades of ADC experience, Pheon arms monoclonal antibodies against both novel and clinically validated t

minimal 11.9 / 100 0 APIs View provider profile →

Company Biotechnology Pharmaceuticals Oncology Antibody-Drug Conjugates Drug Development

Pheon Therapeutics is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.